Decreased Platelet Production [PE] - N0000175972

Pharmacologic Code	N0000175972
Pharmacologic Name	Decreased Platelet Production
Pharmacologic Concept	Physiologic Effects - [PE]
Pharmacologic Concept Description	This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

The table contains 7 products whose active ingredient are classified under the same pharmacologic class Decreased Platelet Production [PE].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0172-5240	Anagrelide Hydrochloride	Non-Proprietary Name: Anagrelide Hydrochloride	Capsule	Oral	Teva Pharmaceuticals Usa, Inc.	ACTIVE
	0172-5241	Anagrelide Hydrochloride	Non-Proprietary Name: Anagrelide Hydrochloride	Capsule	Oral	Teva Pharmaceuticals Usa, Inc.	ACTIVE
	13668-453	Anagrelide	Non-Proprietary Name: Anagrelide	Capsule	Oral	Torrent Pharmaceuticals Limited	ACTIVE
	13668-462	Anagrelide	Non-Proprietary Name: Anagrelide	Capsule	Oral	Torrent Pharmaceuticals Limited	ACTIVE
	54092-063	Agrylin	Non-Proprietary Name: Anagrelide Hydrochloride	Capsule	Oral	Takeda Pharmaceuticals America, Inc.	ACTIVE
	62135-312	Anagrelide	Non-Proprietary Name: Anagrelide	Capsule	Oral	Chartwell Rx, Llc	ACTIVE
	62135-313	Anagrelide	Non-Proprietary Name: Anagrelide	Capsule	Oral	Chartwell Rx, Llc	ACTIVE